RE:Trial and errorThe board lacks exteral business professionals. Too many MS's - they tend to think they know better than others regardless of subject... It's very unclear what Alex contribute with.
No wonder the company is weak, naive and lacks focus. I don't think they even have a written business plan.
Unfortunately the granting of options and bonuses would be challenged if the board would be extended with board professionals.
Yes, I regret my investment - would have grown much more elsewhere. Biotech is risky business and one should expect very profitable deals in return, but still no sign of the latter. They need to nail something soon or I'll get out.